Multiple genetic alterations in vitamin K epoxide reductase complex subunit 1 gene (VKORC1) can explain the high dose requirement during oral anticoagulation in humans

Authors


Marie-Anne Loriot, Université Paris Descartes, INSERM U-775, 45 rue des Saints-Pères, 75006 Paris, France.
Tel.: +33 1 42 86 20 72; fax: +33 1 42 86 20 72.
E-mail: marie-anne.loriot@univ-paris5.fr

No abstract is available for this article.

Ancillary